Related Experiment Video

Updated: Jun 28, 2026

Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
09:51

Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators

Published on: March 21, 2018

Looking back at pediatrics to move forward in obstetrics

Neal Halfon1, Helen DuPlessis, Emily Barrett

  • 1David Geffen School of Medicine, UCLA School of Public Health, USA. nhalfon@ucla.edu

Current Opinion in Obstetrics & Gynecology
|November 8, 2008
PubMed

Insights

The Life Course Health Development (LCHD) model offers a framework to improve women's reproductive health by integrating early life experiences into healthcare. This approach can enhance obstetric care and optimize women's reproductive readiness.

Area of Science:

  • Reproductive Health
  • Public Health
  • Systems Science

Background:

  • Current obstetrical care systems require reevaluation.
  • The Life Course Health Development (LCHD) model provides a framework for understanding lifelong health.
  • Integrating LCHD principles can improve care for women of childbearing age.

Purpose of the Study:

  • To assess the current state of obstetrical care.
  • To discuss the implications of the LCHD model for women's healthcare systems.
  • To identify strategies from child health systems for adaptation to women's health.

Main Methods:

  • Literature review and synthesis of evidence on the LCHD model.
  • Analysis of existing child health programs for transferable strategies.
  • Conceptualization of a reengineered obstetrics and women's healthcare system.

Main Results:

  • The LCHD model integrates developmental origins of health and disease (DOHaD) evidence.
  • Knowledge of early life influences can inform redesign of healthcare delivery.
  • The child health system demonstrates successful implementation of evidence-based programs to promote health and prevent risk.

Conclusions:

  • Obstetricians and public health researchers are adopting the LCHD model.
  • The LCHD model can reconceptualize health trajectories and improve reproductive outcomes.
  • Recommendations are provided for reengineering obstetrics and women's healthcare using the LCHD model to optimize reproductive readiness.
Abstract

More Related Videos

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling07:11

Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

Published on: February 5, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and are...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
ATP Driven Pumps II: P-type Pumps01:34

ATP Driven Pumps II: P-type Pumps

The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including: